Gillespie B R, Burns G A, Ritter R C
Department of Veterinary Comparative Anatomy Physiology Pharmacology, College of Veterinary Medicine, Washington State Univ., Rm. 205 Wegner Hall, Pullman, Washington 99164-6520, USA.
Am J Physiol Regul Integr Comp Physiol. 2005 Nov;289(5):R1504-11. doi: 10.1152/ajpregu.00169.2005. Epub 2005 Jul 14.
The N-methyl-D-aspartate (NMDA) ion channel blocker MK-801 administered systemically or as a nanoliter injection into the nucleus of the solitary tract (NTS), increases meal size. Furthermore, we have observed that ablation of the NTS abolishes increased meal size following systemic injection of dizocilpine (MK-801) and that MK-801-induced increases in intake are attenuated in rats pretreated with capsaicin to destroy small, unmyelinated, primary afferent neurons. These findings led us to hypothesize that NMDA receptors on central vagal afferent terminals or on higher-order NTS neurons innervated by these vagal afferents might mediate increased food intake. To evaluate this hypothesis, we examined 15% sucrose intake after 50-nl MK-801 injections ipsilateral or contralateral to unilateral nodose ganglion removal (ganglionectomy). On the side contralateral to ganglionectomy, vagal afferent terminals would be intact and functional, whereas ipsilateral to ganglionectomy vagal afferent terminals would be absent. Three additional control preparations also were included: 1) sham ganglionectomy and 2) subnodose vagotomy either contralateral or ipsilateral to NTS cannula placement. We found that rats with subnodose vagotomies increased their sucrose intake after injections of MK-801 compared with saline, regardless of whether injections were made contralateral (12.6 +/- 0.2 vs. 9.6 +/- 0.3 ml) or ipsilateral (14.2 +/- 0.6 vs. 9.7 +/- 0.4 ml) to vagotomy. Rats with NTS cannula placements contralateral to nodose ganglionectomy also increased their intake after MK-801 (12.2 +/- 0.9 and 9.2 +/- 1.1 ml for MK-801 and saline, respectively). However, rats with placements ipsilateral to ganglionectomy did not respond to MK-801 (8.0 +/- 0.5 ml) compared with saline (8.3 +/- 0.4 ml). We conclude that central vagal afferent terminals are necessary for increased food intake in response to NMDA ion channel blockade. The function of central vagal afferent processes or the activity of higher-order NTS neurons driven by vagal afferents may be modulated by NMDA receptors to control meal size.
全身性给予N-甲基-D-天冬氨酸(NMDA)离子通道阻滞剂MK-801,或将其以纳升量注射到孤束核(NTS)中,会增加进食量。此外,我们观察到,切除NTS可消除全身注射地佐环平(MK-801)后进食量的增加,并且在用辣椒素预处理以破坏细小的、无髓鞘的初级传入神经元的大鼠中,MK-801诱导的摄入量增加会减弱。这些发现使我们推测,中枢迷走神经传入终末上的NMDA受体,或受这些迷走神经传入支配的高阶NTS神经元上的NMDA受体,可能介导进食量增加。为了评估这一假设,我们检查了在单侧结状神经节切除(神经节切除术)同侧或对侧注射50纳升MK-801后15%蔗糖的摄入量。在神经节切除术的对侧,迷走神经传入终末将保持完整且功能正常,而在神经节切除术的同侧,迷走神经传入终末将缺失。还包括另外三种对照制剂:1)假神经节切除术和2)在NTS插管放置的对侧或同侧进行结状神经节下迷走神经切断术。我们发现,无论注射是在迷走神经切断术的对侧(12.6±0.2对9.6±0.3毫升)还是同侧(14.2±0.6对9.7±0.4毫升)进行,结状神经节下迷走神经切断术的大鼠在注射MK-801后与注射生理盐水相比,蔗糖摄入量增加。结状神经节切除术对侧放置NTS插管的大鼠在注射MK-801后摄入量也增加(MK-801组和生理盐水组分别为12.2±0.9和9.2±1.1毫升)。然而,与生理盐水组(8.3±0.4毫升)相比,神经节切除术同侧放置插管的大鼠对MK-801无反应(8.0±0.5毫升)。我们得出结论,中枢迷走神经传入终末是NMDA离子通道阻滞引起进食量增加所必需的。中枢迷走神经传入过程的功能或由迷走神经传入驱动的高阶NTS神经元的活动可能受NMDA受体调节,以控制进食量。